SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Street Walker who wrote (474)4/9/1999 9:20:00 AM
From: Bo Didley  Read Replies (1) of 5582
 
Smart Money Article

messages.yahoo.com

"Watson has also recently won approval from the FDA for the first generic version of Nicorette gum. This market is estimated to be worth $200 million and a competitor's product is not expected to be available for quite some time. There just aren't too many drug companies that have figured out how to make gum. This product should be on the market by the summer."

Any chance Watson will pick GUMM ? Summer is about here and
Watson Pharmaceutical needs someone to hurry and start producing it.

bo
ps SW - glad to see you back posting.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext